Table 2.
Productive countries in research on risk assessment of Cryptosporidium with at least 7 articles
| Country | SC(%)R | MC(%)R | TP(%)R | FA(%)R | CA(%)R |
|---|---|---|---|---|---|
| United States | 86(39.27)1 | 65(78.31)1 | 151(50)1 | 113(37.42)1 | 118(39.07)1 |
| United Kingdom | 28(12.79)2 | 16(19.28)2 | 44(14.57)2 | 36(11.92)2 | 38(12.58)2 |
| Australia | 21(9.59)3 | 15(18.07)3 | 36(11.92)3 | 28(9.27)3 | 26(8.61)3 |
| Canada | 21(9.59)3 | 9(10.84)4 | 30(9.93)4 | 26(8.61)4 | 25(8.28)4 |
| Netherlands | 12(5.48)5 | 5(6.02)7 | 17(5.63)5 | 15(4.97)5 | 13(4.3)5 |
| France | 8(3.65)6 | 8(9.64)5 | 16(5.3)6 | 11(3.64)6 | 13(4.3)5 |
| Sweden | 1(0.46)18 | 6(7.23)6 | 7(2.32)7 | 4(1.32)9 | 5(1.66)7 |
TP, Total publications; R, Rank; SC, Single country publications; MC, Multiple countries publications; FA, First author publications; CA, Corresponding author publications.